2. Signaling Pathways
  3. Immunology/Inflammation
  4. IRAK
  5. IRAK Ligand

IRAK Ligand

IRAK Isoform Comparison

IRAK Ligand (1):

Cat. No. Product Name Effect Purity
  • HY-172406
    MAPK-IN-4
    		Ligand
    MAPK-IN-4 (Compound c1) is an orally active anti-inflammatory agent. MAPK-IN-4 can inhibit the expression and release of pro-inflammatory cytokines IL-6 and TNF-α induced by LPS (HY-D1056). MAPK-IN-4 can bind to IRAK4 and exert its anti-inflammatory effect by inhibiting the MAPK pathway.